Skip to main content
. 2006 Jan;26(2):472–479. doi: 10.1128/MCB.26.2.472-479.2006

FIG. 5.

FIG. 5.

VSV protection assay. (A) Wild-type and Ube1L knockout MEFs were left untreated or treated with 100 or 1,000 U/ml of IFN-β for 24 h, followed by VSV infection ranging from a multiplicity of infection of 0 to 104 per well for an additional 24 h. Cell viability was assessed by crystal violet staining. (B) Ube1L+/+ (n = 5) and Ube1L−/− (n = 5) mice were infected intracerebrally with 1,000 PFU of LCMV and monitored daily for development of clinical symptoms and survival.